Lataa...
Survivin-T34A: molecular mechanism and therapeutic potential
The inhibitor of apoptosis protein survivin’s threonine 34 to alanine (T34A) mutation abolishes a phosphorylation site for p34(cdc2)–cyclin B1, resulting in initiation of the mitochondrial apoptotic pathway in cancer cells; however, it has little known direct effects on normal cells. The possibility...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3024888/ https://ncbi.nlm.nih.gov/pubmed/21289859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S15293 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|